<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37009800</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2092-6413</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Experimental &amp; molecular medicine</Title><ISOAbbreviation>Exp Mol Med</ISOAbbreviation></Journal><ArticleTitle>Glutathionylation on RNA-binding proteins: a regulator of liquid&#x2012;liquid phase separation in the pathogenesis of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>735</StartPage><EndPage>744</EndPage><MedlinePgn>735-744</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s12276-023-00978-2</ELocationID><Abstract><AbstractText>RNA-binding proteins (RBPs) containing low-sequence complexity domains mediate the formation of cellular condensates and membrane-less organelles with biological functions via liquid&#x2012;liquid phase separation (LLPS). However, the abnormal phase transition of these proteins induces the formation of insoluble aggregates. Aggregates are pathological hallmarks of neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS). The molecular mechanisms underlying aggregate formation by ALS-associated RPBs remain largely unknown. This review highlights emerging studies on various posttranslational modifications (PTMs) related to protein aggregation. We begin with the introduction of several ALS-associated RBPs that form aggregates induced by phase separation. In addition, we highlight our recent discovery of a new PTM involved in the phase transition during the pathogenesis of fused-in-sarcoma (FUS)-associated ALS. We suggest a molecular mechanism through which LLPS mediates glutathionylation in FUS-linked ALS. This review aims to provide a detailed overview of the key molecular mechanisms of LLPS-mediated aggregate formation by PTMs, which will help further the understanding of the pathogenesis and development of ALS therapeutics.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Hyun-Jun</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Soonchunhyang Institute of Medi-bio Science, Soonchunhyang University, Cheonan, 31151, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Integrated Biomedical Sciences, Soonchunhyang University, Cheonan, 31151, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ji Young</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology, Soonchunhyang University, Asan, 31538, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Science, Soonchunhyang University, Asan, 31538, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kiyoung</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-4879-5207</Identifier><AffiliationInfo><Affiliation>Department of Medical Science, Soonchunhyang University, Asan, 31538, Korea. kiyoung2@sch.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Exp Mol Med</MedlineTA><NlmUniqueID>9607880</NlmUniqueID><ISSNLinking>1226-3613</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>5</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37009800</ArticleId><ArticleId IdType="pmc">PMC10167235</ArticleId><ArticleId IdType="doi">10.1038/s12276-023-00978-2</ArticleId><ArticleId IdType="pii">10.1038/s12276-023-00978-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rosen DR, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A, Logroscino G, Jick SS, Hern&#xe1;n MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population&#x2010;based study. Eur. J. Neurol. 2009;16:745&#x2013;751. doi: 10.1111/j.1468-1331.2009.02586.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02586.x</ArticleId><ArticleId IdType="pmc">PMC3093130</ArticleId><ArticleId IdType="pubmed">19475756</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2001;2:806&#x2013;819. doi: 10.1038/35097565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35097565</ArticleId><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K, Martinez FJ, Yeo GW. Genetic mutations in RNA-binding proteins and their roles in ALS. Hum. Genet. 2017;136:1193&#x2013;1214. doi: 10.1007/s00439-017-1830-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-017-1830-7</ArticleId><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Kim JR, van Bruggen R, Park J. RNA-binding proteins in amyotrophic lateral sclerosis. Mol. Cells. 2018;41:818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6182225</ArticleId><ArticleId IdType="pubmed">30157547</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman MS, Trojanowski JQ, Lee VM. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med. 2004;10:1055&#x2013;1063. doi: 10.1038/nm1113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1113</ArticleId><ArticleId IdType="pubmed">15459709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat. Med. 2004;10:S10&#x2013;S17. doi: 10.1038/nm1066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1066</ArticleId><ArticleId IdType="pubmed">15272267</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006;75:333&#x2013;366. doi: 10.1146/annurev.biochem.75.101304.123901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.75.101304.123901</ArticleId><ArticleId IdType="pubmed">16756495</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin Y, Brangwynne CP. Liquid phase condensation in cell physiology and disease. Science. 2017;357:eaaf4382. doi: 10.1126/science.aaf4382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf4382</ArticleId><ArticleId IdType="pubmed">28935776</ArticleId></ArticleIdList></Reference><Reference><Citation>Banani SF, Lee HO, Hyman AA, Rosen MK. Biomolecular condensates: organizers of cellular biochemistry. Nat. Rev. Mol. Cell Biol. 2017;18:285&#x2013;298. doi: 10.1038/nrm.2017.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.7</ArticleId><ArticleId IdType="pmc">PMC7434221</ArticleId><ArticleId IdType="pubmed">28225081</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, et al. Liquid-liquid phase separation in biology: mechanisms, physiological functions and human diseases. Sci. China Life Sci. 2020;63:953&#x2013;985. doi: 10.1007/s11427-020-1702-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-020-1702-x</ArticleId><ArticleId IdType="pubmed">32548680</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan JR, Parker R. Eukaryotic stress granules: the ins and outs of translation. Mol. Cell. 2009;36:932&#x2013;941. doi: 10.1016/j.molcel.2009.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2009.11.020</ArticleId><ArticleId IdType="pmc">PMC2813218</ArticleId><ArticleId IdType="pubmed">20064460</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong K-w, et al. Whole-genome screening identifies proteins localized to distinct nuclear bodies. J. Cell Biol. 2013;203:149&#x2013;164. doi: 10.1083/jcb.201303145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201303145</ArticleId><ArticleId IdType="pmc">PMC3798253</ArticleId><ArticleId IdType="pubmed">24127217</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrea DM, Kriwacki RW. Phase separation in biology; functional organization of a higher order. Cell Commun. Signal. 2016;14:1&#x2013;20. doi: 10.1186/s12964-015-0125-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-015-0125-7</ArticleId><ArticleId IdType="pmc">PMC4700675</ArticleId><ArticleId IdType="pubmed">26727894</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes E, Shorter J. The molecular language of membraneless organelles. J. Biol. Chem. 2019;294:7115&#x2013;7127. doi: 10.1074/jbc.TM118.001192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.TM118.001192</ArticleId><ArticleId IdType="pmc">PMC6509512</ArticleId><ArticleId IdType="pubmed">30045872</ArticleId></ArticleIdList></Reference><Reference><Citation>Sehgal PB, Westley J, Lerea KM, DiSenso-Browne S, Etlinger JD. Biomolecular condensates in cell biology and virology: phase-separated membraneless organelles (MLOs) Anal. Biochem. 2020;597:113691. doi: 10.1016/j.ab.2020.113691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ab.2020.113691</ArticleId><ArticleId IdType="pubmed">32194074</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai AK, Chen J-X, Selbach M, Pelkmans L. Kinase-controlled phase transition of membraneless organelles in mitosis. Nature. 2018;559:211&#x2013;216. doi: 10.1038/s41586-018-0279-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0279-8</ArticleId><ArticleId IdType="pubmed">29973724</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Zhang H. Phase separation, transition, and autophagic degradation of proteins in development and pathogenesis. Trends Cell Biol. 2019;29:417&#x2013;427. doi: 10.1016/j.tcb.2019.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2019.01.008</ArticleId><ArticleId IdType="pubmed">30826216</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswami M, Taylor JP, Parker R. Altered ribostasis: RNA-protein granules in degenerative disorders. Cell. 2013;154:727&#x2013;736. doi: 10.1016/j.cell.2013.07.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.07.038</ArticleId><ArticleId IdType="pmc">PMC3811119</ArticleId><ArticleId IdType="pubmed">23953108</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonicka H, Shoubridge EA. Mitochondrial RNA granules are centers for posttranscriptional RNA processing and ribosome biogenesis. Cell Rep. 2015;10:920&#x2013;932. doi: 10.1016/j.celrep.2015.01.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.01.030</ArticleId><ArticleId IdType="pubmed">25683715</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi A, Altmeyer M. Phase separation: linking cellular compartmentalization to disease. Trends Cell Biol. 2016;26:547&#x2013;558. doi: 10.1016/j.tcb.2016.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2016.03.004</ArticleId><ArticleId IdType="pubmed">27051975</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky NB, Taylor JP. Bridging biophysics and neurology: aberrant phase transitions in neurodegenerative disease. Nat. Rev. Neurol. 2019;15:272&#x2013;286. doi: 10.1038/s41582-019-0157-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0157-5</ArticleId><ArticleId IdType="pubmed">30890779</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan VH, Fawzi NL. Physiological, pathological, and targetable membraneless organelles in neurons. Trends Neurosci. 2019;42:693&#x2013;708. doi: 10.1016/j.tins.2019.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2019.08.005</ArticleId><ArticleId IdType="pmc">PMC6779520</ArticleId><ArticleId IdType="pubmed">31493925</ArticleId></ArticleIdList></Reference><Reference><Citation>Zbinden A, Perez-Berlanga M, De Rossi P, Polymenidou M. Phase separation and neurodegenerative diseases: a disturbance in the force. Dev. Cell. 2020;55:45&#x2013;68. doi: 10.1016/j.devcel.2020.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2020.09.014</ArticleId><ArticleId IdType="pubmed">33049211</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S, Gladfelter A, Mittag T. Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates. Cell. 2019;176:419&#x2013;434. doi: 10.1016/j.cell.2018.12.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.12.035</ArticleId><ArticleId IdType="pmc">PMC6445271</ArticleId><ArticleId IdType="pubmed">30682370</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan G, Walther D. The roles of post-translational modifications in the context of protein interaction networks. PLoS Comput. Biol. 2015;11:e1004049. doi: 10.1371/journal.pcbi.1004049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1004049</ArticleId><ArticleId IdType="pmc">PMC4333291</ArticleId><ArticleId IdType="pubmed">25692714</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabakaran S, Lippens G, Steen H, Gunawardena J. Post-translational modification: nature&#x2019;s escape from genetic imprisonment and the basis for dynamic information encoding. Wires Syst. Biol. Med. 2012;4:565&#x2013;583. doi: 10.1002/wsbm.1185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wsbm.1185</ArticleId><ArticleId IdType="pmc">PMC3473174</ArticleId><ArticleId IdType="pubmed">22899623</ArticleId></ArticleIdList></Reference><Reference><Citation>Snead WT, Gladfelter AS. The control centers of biomolecular phase separation: how membrane surfaces, PTMs, and active processes regulate condensation. Mol. Cell. 2019;76:295&#x2013;305. doi: 10.1016/j.molcel.2019.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.09.016</ArticleId><ArticleId IdType="pmc">PMC7173186</ArticleId><ArticleId IdType="pubmed">31604601</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y-Y, Wu J-J, Li Y-M. Regulation of liquid-liquid phase separation with focus on post-translational modifications. Chem. Commun. 2021;57:13275&#x2013;13287. doi: 10.1039/D1CC05266G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1CC05266G</ArticleId><ArticleId IdType="pubmed">34816836</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen I, Shewmaker F. The role of post-translational modifications in the phase transitions of intrinsically disordered proteins. Int. J. Mol. Sci. 2019;20:5501. doi: 10.3390/ijms20215501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20215501</ArticleId><ArticleId IdType="pmc">PMC6861982</ArticleId><ArticleId IdType="pubmed">31694155</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong JY, Torres JZ. Phase separation in cell division. Mol. Cell. 2020;80:9&#x2013;20. doi: 10.1016/j.molcel.2020.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.08.007</ArticleId><ArticleId IdType="pmc">PMC7541545</ArticleId><ArticleId IdType="pubmed">32860741</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, et al. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163:123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Markmiller S, et al. Context-dependent and disease-specific diversity in protein interactions within stress granules. Cell. 2018;172:590&#x2013;604. e513. doi: 10.1016/j.cell.2017.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.032</ArticleId><ArticleId IdType="pmc">PMC5969999</ArticleId><ArticleId IdType="pubmed">29373831</ArticleId></ArticleIdList></Reference><Reference><Citation>Babinchak WM, et al. The role of liquid&#x2013;liquid phase separation in aggregation of the TDP-43 low-complexity domain. J. Biol. Chem. 2019;294:6306&#x2013;6317. doi: 10.1074/jbc.RA118.007222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.007222</ArticleId><ArticleId IdType="pmc">PMC6484124</ArticleId><ArticleId IdType="pubmed">30814253</ArticleId></ArticleIdList></Reference><Reference><Citation>Murthy AC, et al. Molecular interactions underlying liquid&#x2212;liquid phase separation of the FUS low-complexity domain. Nat. Struct. Mol. Biol. 2019;26:637&#x2013;648. doi: 10.1038/s41594-019-0250-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0250-x</ArticleId><ArticleId IdType="pmc">PMC6613800</ArticleId><ArticleId IdType="pubmed">31270472</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S, Halfmann R, King O, Kapila A, Lindquist S. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell. 2009;137:146&#x2013;158. doi: 10.1016/j.cell.2009.02.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.02.044</ArticleId><ArticleId IdType="pmc">PMC2683788</ArticleId><ArticleId IdType="pubmed">19345193</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M, et al. Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell. 2012;149:753&#x2013;767. doi: 10.1016/j.cell.2012.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.017</ArticleId><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Malinovska L, Palm S, Gibson K, Verbavatz J-M, Alberti S. Dictyostelium discoideum has a highly Q/N-rich proteome and shows an unusual resilience to protein aggregation. Proc. Natl Acad. Sci. USA. 2015;112:E2620&#x2013;E2629. doi: 10.1073/pnas.1504459112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1504459112</ArticleId><ArticleId IdType="pmc">PMC4443358</ArticleId><ArticleId IdType="pubmed">25941378</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyson HJ. Expanding the proteome: disordered and alternatively folded proteins. Q. Rev. Biophys. 2011;44:467&#x2013;518. doi: 10.1017/S0033583511000060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033583511000060</ArticleId><ArticleId IdType="pmc">PMC3189428</ArticleId><ArticleId IdType="pubmed">21729349</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, et al. Phase transitions in the assembly of multivalent signalling proteins. Nature. 2012;483:336&#x2013;340. doi: 10.1038/nature10879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10879</ArticleId><ArticleId IdType="pmc">PMC3343696</ArticleId><ArticleId IdType="pubmed">22398450</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. A molecular grammar governing the driving forces for phase separation of prion-like RNA binding proteins. Cell. 2018;174:688&#x2013;699. e616. doi: 10.1016/j.cell.2018.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.06.006</ArticleId><ArticleId IdType="pmc">PMC6063760</ArticleId><ArticleId IdType="pubmed">29961577</ArticleId></ArticleIdList></Reference><Reference><Citation>Nott TJ, et al. Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles. Mol. Cell. 2015;57:936&#x2013;947. doi: 10.1016/j.molcel.2015.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.01.013</ArticleId><ArticleId IdType="pmc">PMC4352761</ArticleId><ArticleId IdType="pubmed">25747659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, et al. Complexation and coacervation of like-charged polyelectrolytes inspired by mussels. Proc. Natl Acad. Sci. USA. 2016;113:E847&#x2013;E853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4763778</ArticleId><ArticleId IdType="pubmed">26831090</ArticleId></ArticleIdList></Reference><Reference><Citation>Pak CW, et al. Sequence determinants of intracellular phase separation by complex coacervation of a disordered protein. Mol. Cell. 2016;63:72&#x2013;85. doi: 10.1016/j.molcel.2016.05.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.05.042</ArticleId><ArticleId IdType="pmc">PMC4973464</ArticleId><ArticleId IdType="pubmed">27392146</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J, Lim L, Lu Y, Song J. A unified mechanism for LLPS of ALS/FTLD-causing FUS as well as its modulation by ATP and oligonucleic acids. PLoS Biol. 2019;17:e3000327. doi: 10.1371/journal.pbio.3000327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000327</ArticleId><ArticleId IdType="pmc">PMC6590835</ArticleId><ArticleId IdType="pubmed">31188823</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S, Lin Y-H, Vernon RM, Forman-Kay JD, Chan HS. Comparative roles of charge, &#x3c0;, and hydrophobic interactions in sequence-dependent phase separation of intrinsically disordered proteins. Proc. Natl Acad. Sci. USA. 2020;117:28795&#x2013;28805. doi: 10.1073/pnas.2008122117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2008122117</ArticleId><ArticleId IdType="pmc">PMC7682375</ArticleId><ArticleId IdType="pubmed">33139563</ArticleId></ArticleIdList></Reference><Reference><Citation>Brangwynne CP, Tompa P, Pappu RV. Polymer physics of intracellular phase transitions. Nat. Phys. 2015;11:899&#x2013;904. doi: 10.1038/nphys3532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nphys3532</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, et al. Protein phase separation: a new phase in cell biology. Trends Cell Biol. 2018;28:420&#x2013;435. doi: 10.1016/j.tcb.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2018.02.004</ArticleId><ArticleId IdType="pmc">PMC6034118</ArticleId><ArticleId IdType="pubmed">29602697</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, et al. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 2009;284:20329&#x2013;20339. doi: 10.1074/jbc.M109.010264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, Zerze GH, Mittal J, Fawzi NL. ALS mutations disrupt phase separation mediated by &#x3b1;-helical structure in the TDP-43 low-complexity C-terminal domain. Structure. 2016;24:1537&#x2013;1549. doi: 10.1016/j.str.2016.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2016.07.007</ArticleId><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt HB, Rohatgi R. In vivo formation of vacuolated multi-phase compartments lacking membranes. Cell Rep. 2016;16:1228&#x2013;1236. doi: 10.1016/j.celrep.2016.06.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.06.088</ArticleId><ArticleId IdType="pmc">PMC4972689</ArticleId><ArticleId IdType="pubmed">27452472</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, et al. TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron. 2017;95:808&#x2013;816. e809. doi: 10.1016/j.neuron.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao TP, et al. ALS-linked mutations affect UBQLN2 oligomerization and phase separation in a position-and amino acid-dependent manner. Structure. 2019;27:937&#x2013;951. e935. doi: 10.1016/j.str.2019.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2019.03.012</ArticleId><ArticleId IdType="pmc">PMC6551275</ArticleId><ArticleId IdType="pubmed">30982635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X, Gu S, Xue S, Luo S-Z. Disease-associated mutations affect TIA1 phase separation and aggregation in a proline-dependent manner. Brain Res. 2021;1768:147589. doi: 10.1016/j.brainres.2021.147589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2021.147589</ArticleId><ArticleId IdType="pubmed">34310938</ArticleId></ArticleIdList></Reference><Reference><Citation>Grese ZR, et al. Specific RNA interactions promote TDP&#x2010;43 multivalent phase separation and maintain liquid properties. EMBO Rep. 2021;22:e53632. doi: 10.15252/embr.202153632.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202153632</ArticleId><ArticleId IdType="pmc">PMC8647020</ArticleId><ArticleId IdType="pubmed">34787357</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson MK, et al. The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol. 2008;9:1&#x2013;17. doi: 10.1186/1471-2121-9-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2121-9-37</ArticleId><ArticleId IdType="pmc">PMC2478660</ArticleId><ArticleId IdType="pubmed">18620564</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C, et al. TDP&#x2010;43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 2009;111:1051&#x2013;1061. doi: 10.1111/j.1471-4159.2009.06383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan AY, Manley JL. The TET family of proteins: functions and roles in disease. J. Mol. Cell Biol. 2009;1:82&#x2013;92. doi: 10.1093/jmcb/mjp025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjp025</ArticleId><ArticleId IdType="pmc">PMC2905059</ArticleId><ArticleId IdType="pubmed">19783543</ArticleId></ArticleIdList></Reference><Reference><Citation>March ZM, King OD, Shorter J. Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease. Brain Res. 2016;1647:9&#x2013;18. doi: 10.1016/j.brainres.2016.02.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.02.037</ArticleId><ArticleId IdType="pmc">PMC5003744</ArticleId><ArticleId IdType="pubmed">26996412</ArticleId></ArticleIdList></Reference><Reference><Citation>Loughlin FE, et al. The solution structure of FUS bound to RNA reveals a bipartite mode of RNA recognition with both sequence and shape specificity. Mol. Cell. 2019;73:490&#x2013;504. e496. doi: 10.1016/j.molcel.2018.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.11.012</ArticleId><ArticleId IdType="pubmed">30581145</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo F, et al. Atomic structures of FUS LC domain segments reveal bases for reversible amyloid fibril formation. Nat. Struct. Mol. Biol. 2018;25:341&#x2013;346. doi: 10.1038/s41594-018-0050-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-018-0050-8</ArticleId><ArticleId IdType="pubmed">29610493</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray DT, et al. Structure of FUS protein fibrils and its relevance to self-assembly and phase separation of low-complexity domains. Cell. 2017;171:615&#x2013;627. e616. doi: 10.1016/j.cell.2017.08.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.08.048</ArticleId><ArticleId IdType="pmc">PMC5650524</ArticleId><ArticleId IdType="pubmed">28942918</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray DT, Tycko R. Side chain hydrogen-bonding interactions within amyloid-like fibrils formed by the low-complexity domain of FUS: evidence from solid state nuclear magnetic resonance spectroscopy. Biochemistry. 2020;59:364&#x2013;378. doi: 10.1021/acs.biochem.9b00892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.9b00892</ArticleId><ArticleId IdType="pmc">PMC7262780</ArticleId><ArticleId IdType="pubmed">31895552</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M, Ghosh U, Thurber KR, Kato M, Tycko R. Molecular structure and interactions within amyloid-like fibrils formed by a low-complexity protein sequence from FUS. Nat. Commun. 2020;11:1&#x2013;14. doi: 10.1038/s41467-020-19512-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19512-3</ArticleId><ArticleId IdType="pmc">PMC7665218</ArticleId><ArticleId IdType="pubmed">33184287</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, et al. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162:1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X, et al. Amyloid-forming segment induces aggregation of FUS-LC domain from phase separation modulated by site-specific phosphorylation. J. Mol. Biol. 2020;432:467&#x2013;483. doi: 10.1016/j.jmb.2019.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2019.11.017</ArticleId><ArticleId IdType="pubmed">31805282</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, et al. The SGYS motif of TAF15 prion-like domain is critical to amyloid fibril formation. Biophys. J. 2022;121:2613&#x2013;2623. doi: 10.1016/j.bpj.2022.05.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2022.05.038</ArticleId><ArticleId IdType="pmc">PMC9300678</ArticleId><ArticleId IdType="pubmed">35643629</ArticleId></ArticleIdList></Reference><Reference><Citation>Nosella ML, et al. O-linked-N-acetylglucosaminylation of the RNA-binding protein EWS N-terminal low complexity region reduces phase separation and enhances condensate dynamics. J. Am. Chem. Soc. 2021;143:11520&#x2013;11534. doi: 10.1021/jacs.1c04194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.1c04194</ArticleId><ArticleId IdType="pubmed">34304571</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong S, et al. Tuning levels of low-complexity domain interactions to modulate endogenous oncogenic transcription. Mol. Cell. 2022;82:2084&#x2013;2097.e5. doi: 10.1016/j.molcel.2022.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.04.007</ArticleId><ArticleId IdType="pubmed">35483357</ArticleId></ArticleIdList></Reference><Reference><Citation>Mompe&#xe1;n M, et al. The TDP&#x2010;43 N&#x2010;terminal domain structure at high resolution. FEBS J. 2016;283:1242&#x2013;1260. doi: 10.1111/febs.13651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13651</ArticleId><ArticleId IdType="pubmed">26756435</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C-k, et al. The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity. Biochem. Biophys. Res. Commun. 2012;425:219&#x2013;224. doi: 10.1016/j.bbrc.2012.07.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.07.071</ArticleId><ArticleId IdType="pubmed">22835933</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ambrogio A, et al. Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. Nucleic Acids Res. 2009;37:4116&#x2013;4126. doi: 10.1093/nar/gkp342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp342</ArticleId><ArticleId IdType="pmc">PMC2709582</ArticleId><ArticleId IdType="pubmed">19429692</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano M, et al. Evolutionarily conserved heterogeneous nuclear ribonucleoprotein (hnRNP) A/B proteins functionally interact with human and Drosophila TAR DNA-binding protein 43 (TDP-43) J. Biol. Chem. 2014;289:7121&#x2013;7130. doi: 10.1074/jbc.M114.548859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.548859</ArticleId><ArticleId IdType="pmc">PMC3945372</ArticleId><ArticleId IdType="pubmed">24492607</ArticleId></ArticleIdList></Reference><Reference><Citation>Geuens T, Bouhy D, Timmerman V. The hnRNP family: insights into their role in health and disease. Hum. Genet. 2016;135:851&#x2013;867. doi: 10.1007/s00439-016-1683-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-016-1683-5</ArticleId><ArticleId IdType="pmc">PMC4947485</ArticleId><ArticleId IdType="pubmed">27215579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495:467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Han TW, et al. Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. Cell. 2012;149:768&#x2013;779. doi: 10.1016/j.cell.2012.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.016</ArticleId><ArticleId IdType="pubmed">22579282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma M-R, Hu Z-W, Zhao Y-F, Chen Y-X, Li Y-M. Phosphorylation induces distinct alpha-synuclein strain formation. Sci. Rep. 2016;6:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5112567</ArticleId><ArticleId IdType="pubmed">27853185</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z-W, et al. Phosphorylation at Ser8 as an intrinsic regulatory switch to regulate the morphologies and structures of Alzheimer&#x2019;s 40-residue &#x3b2;-amyloid (A&#x3b2;40) fibrils. J. Biol. Chem. 2017;292:2611&#x2013;2623. doi: 10.1074/jbc.M116.757179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.757179</ArticleId><ArticleId IdType="pmc">PMC5314160</ArticleId><ArticleId IdType="pubmed">28031462</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M, Dormann D. Friend or foe&#x2014;post-translational modifications as regulators of phase separation and RNP granule dynamics. J. Biol. Chem. 2019;294:7137&#x2013;7150. doi: 10.1074/jbc.TM118.001189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.TM118.001189</ArticleId><ArticleId IdType="pmc">PMC6509508</ArticleId><ArticleId IdType="pubmed">30587571</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z, et al. Phosphorylation of the FUS low&#x2010;complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J. 2017;36:2951&#x2013;2967. doi: 10.15252/embj.201696394.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201696394</ArticleId><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Currie SL, Rosen MK. Intrinsically disordered sequences enable modulation of protein phase separation through distributed tyrosine motifs. J. Biol. Chem. 2017;292:19110&#x2013;19120. doi: 10.1074/jbc.M117.800466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.800466</ArticleId><ArticleId IdType="pmc">PMC5704491</ArticleId><ArticleId IdType="pubmed">28924037</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A, et al. A single N&#x2010;terminal phosphomimic disrupts TDP&#x2010;43 polymerization, phase separation, and RNA splicing. EMBO J. 2018;37:e97452. doi: 10.15252/embj.201797452.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797452</ArticleId><ArticleId IdType="pmc">PMC5830921</ArticleId><ArticleId IdType="pubmed">29438978</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornbeck PV, et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 2012;40:D261&#x2013;D270. doi: 10.1093/nar/gkr1122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr1122</ArticleId><ArticleId IdType="pmc">PMC3245126</ArticleId><ArticleId IdType="pubmed">22135298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornbeck PV, et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 2015;43:D512&#x2013;D520. doi: 10.1093/nar/gku1267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku1267</ArticleId><ArticleId IdType="pmc">PMC4383998</ArticleId><ArticleId IdType="pubmed">25514926</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117:137&#x2013;149. doi: 10.1007/s00401-008-0477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0477-9</ArticleId><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady OA, Meng P, Zheng Y, Mao Y, Hu F. Regulation of TDP&#x2010;43 aggregation by phosphorylation andp62/SQSTM1. J. Neurochem. 2011;116:248&#x2013;259. doi: 10.1111/j.1471-4159.2010.07098.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.07098.x</ArticleId><ArticleId IdType="pubmed">21062285</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F, et al. Identification of casein kinase-1 phosphorylation sites on TDP-43. Biochem. Biophys. Res. Commun. 2009;382:405&#x2013;409. doi: 10.1016/j.bbrc.2009.03.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.03.038</ArticleId><ArticleId IdType="pubmed">19285963</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruijs da Silva LA, et al. Disease&#x2010;linked TDP&#x2010;43 hyperphosphorylation suppresses TDP&#x2010;43 condensation and aggregation. EMBO J. 2022;41:e108443. doi: 10.15252/embj.2021108443.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021108443</ArticleId><ArticleId IdType="pmc">PMC9016352</ArticleId><ArticleId IdType="pubmed">35112738</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F, et al. Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains. Sci. Rep. 2016;6:1&#x2013;15. doi: 10.1038/srep23281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23281</ArticleId><ArticleId IdType="pmc">PMC4793195</ArticleId><ArticleId IdType="pubmed">26980269</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan VH, et al. Tyrosine phosphorylation regulates hnRNPA2 granule protein partitioning and reduces neurodegeneration. EMBO J. 2021;40:e105001. doi: 10.15252/embj.2020105001.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020105001</ArticleId><ArticleId IdType="pmc">PMC7849316</ArticleId><ArticleId IdType="pubmed">33349959</ArticleId></ArticleIdList></Reference><Reference><Citation>Lao Z, et al. Insights into the atomistic mechanisms of phosphorylation in disrupting liquid&#x2013;liquid phase separation and aggregation of the FUS low-complexity domain. J. Chem. Inf. Model. 2022;62:3227&#x2013;3238. doi: 10.1021/acs.jcim.2c00414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.2c00414</ArticleId><ArticleId IdType="pubmed">35709363</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon RM, et al. Pi-Pi contacts are an overlooked protein feature relevant to phase separation. eLife. 2018;7:e31486. doi: 10.7554/eLife.31486.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.31486</ArticleId><ArticleId IdType="pmc">PMC5847340</ArticleId><ArticleId IdType="pubmed">29424691</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedford MT, Richard S. Arginine methylation: an emerging regulatorof protein function. Mol. Cell. 2005;18:263&#x2013;272. doi: 10.1016/j.molcel.2005.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2005.04.003</ArticleId><ArticleId IdType="pubmed">15866169</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedford MT, Clarke SG. Protein arginine methylation in mammals: who, what, and why. Mol. Cell. 2009;33:1&#x2013;13. doi: 10.1016/j.molcel.2008.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2008.12.013</ArticleId><ArticleId IdType="pmc">PMC3372459</ArticleId><ArticleId IdType="pubmed">19150423</ArticleId></ArticleIdList></Reference><Reference><Citation>Gayatri S, Bedford MT. Readers of histone methylarginine marks. BBA Gene Regul. Mech. 2014;1839:702&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4099268</ArticleId><ArticleId IdType="pubmed">24583552</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorton BM, Shechter D. Cellular consequences of arginine methylation. Cell. Mol. Life Sci. 2019;76:2933&#x2013;2956. doi: 10.1007/s00018-019-03140-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03140-2</ArticleId><ArticleId IdType="pmc">PMC6642692</ArticleId><ArticleId IdType="pubmed">31101937</ArticleId></ArticleIdList></Reference><Reference><Citation>Guccione E, Richard S. The regulation, functions and clinical relevance of arginine methylation. Nat. Rev. Mol. Cell Biol. 2019;20:642&#x2013;657. doi: 10.1038/s41580-019-0155-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0155-x</ArticleId><ArticleId IdType="pubmed">31350521</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappsilber J, Friesen WJ, Paushkin S, Dreyfuss G, Mann M. Detection of arginine dimethylated peptides by parallel precursor ion scanning mass spectrometry in positive ion mode. Anal. Chem. 2003;75:3107&#x2013;3114. doi: 10.1021/ac026283q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac026283q</ArticleId><ArticleId IdType="pubmed">12964758</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, et al. Arginine methylation next to the PY&#x2010;NLS modulates Transportin binding and nuclear import of FUS. EMBO J. 2012;31:4258&#x2013;4275. doi: 10.1038/emboj.2012.261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.261</ArticleId><ArticleId IdType="pmc">PMC3501225</ArticleId><ArticleId IdType="pubmed">22968170</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations. Acta Neuropathol. 2012;124:705&#x2013;716. doi: 10.1007/s00401-012-1020-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1020-6</ArticleId><ArticleId IdType="pubmed">22842875</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S, et al. FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-&#x3c0; interactions. Cell. 2018;173:720&#x2013;734. e715. doi: 10.1016/j.cell.2018.03.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.056</ArticleId><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M, et al. Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation. Cell. 2018;173:706&#x2013;719. e713. doi: 10.1016/j.cell.2018.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.004</ArticleId><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Friend LR, et al. Arginine methylation of hnRNP A2 does not directly govern its subcellular localization. PloS One. 2013;8:e75669. doi: 10.1371/journal.pone.0075669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0075669</ArticleId><ArticleId IdType="pmc">PMC3787039</ArticleId><ArticleId IdType="pubmed">24098712</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan VH, et al. Mechanistic view of hnRNPA2 low-complexity domain structure, interactions, and phase separation altered by mutation and arginine methylation. Mol. Cell. 2018;69:465&#x2013;479. e467. doi: 10.1016/j.molcel.2017.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.12.022</ArticleId><ArticleId IdType="pmc">PMC5801700</ArticleId><ArticleId IdType="pubmed">29358076</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers G, Simmonds D. Content of citrulline and other amino-acids in a protein of hair follicles. Nature. 1958;182:186&#x2013;187. doi: 10.1038/182186a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/182186a0</ArticleId><ArticleId IdType="pubmed">13566234</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers G. Occurrence of citrulline in proteins. Nature. 1962;194:1149&#x2013;1151. doi: 10.1038/1941149a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/1941149a0</ArticleId><ArticleId IdType="pubmed">14493344</ArticleId></ArticleIdList></Reference><Reference><Citation>Anzilotti C, Pratesi F, Tommasi C, Migliorini P. Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmun. Rev. 2010;9:158&#x2013;160. doi: 10.1016/j.autrev.2009.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2009.06.002</ArticleId><ArticleId IdType="pubmed">19540364</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal S, Thompson PR. Protein arginine deiminases (PADs): biochemistry and chemical biology of protein citrullination. Acc. Chem. Res. 2019;52:818&#x2013;832. doi: 10.1021/acs.accounts.9b00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.accounts.9b00024</ArticleId><ArticleId IdType="pmc">PMC6443095</ArticleId><ArticleId IdType="pubmed">30844238</ArticleId></ArticleIdList></Reference><Reference><Citation>Knuckley B, et al. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3. Biochemistry. 2010;49:4852&#x2013;4863. doi: 10.1021/bi100363t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi100363t</ArticleId><ArticleId IdType="pmc">PMC2884139</ArticleId><ArticleId IdType="pubmed">20469888</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarcsa E, et al. Protein unfolding by peptidylarginine deiminase: substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J. Biol. Chem. 1996;271:30709&#x2013;30716. doi: 10.1074/jbc.271.48.30709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.48.30709</ArticleId><ArticleId IdType="pubmed">8940048</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanikawa C, et al. Citrullination of RGG motifs in FET proteins by PAD4 regulates protein aggregation and ALS susceptibility. Cell Rep. 2018;22:1473&#x2013;1483. doi: 10.1016/j.celrep.2018.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.01.031</ArticleId><ArticleId IdType="pubmed">29425503</ArticleId></ArticleIdList></Reference><Reference><Citation>Drazic A, Myklebust LM, Ree R, Arnesen T. The world of protein acetylation. BBA-Proteins Proteom. 2016;1864:1372&#x2013;1401. doi: 10.1016/j.bbapap.2016.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2016.06.007</ArticleId><ArticleId IdType="pubmed">27296530</ArticleId></ArticleIdList></Reference><Reference><Citation>Narita T, Weinert BT, Choudhary C. Functions and mechanisms of non-histone protein acetylation. Nat. Rev. Mol. Cell Biol. 2019;20:156&#x2013;174. doi: 10.1038/s41580-018-0081-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-018-0081-3</ArticleId><ArticleId IdType="pubmed">30467427</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, et al. Regulation of cellular metabolism by protein lysine acetylation. Science. 2010;327:1000&#x2013;1004. doi: 10.1126/science.1179689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1179689</ArticleId><ArticleId IdType="pmc">PMC3232675</ArticleId><ArticleId IdType="pubmed">20167786</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X-J, Seto E. Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol. Cell. 2008;31:449&#x2013;461. doi: 10.1016/j.molcel.2008.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2008.07.002</ArticleId><ArticleId IdType="pmc">PMC2551738</ArticleId><ArticleId IdType="pubmed">18722172</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia C, Tao Y, Li M, Che T, Qu J. Protein acetylation and deacetylation: An important regulatory modification in gene transcription. Exp. Ther. Med. 2020;20:2923&#x2013;2940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7444376</ArticleId><ArticleId IdType="pubmed">32855658</ArticleId></ArticleIdList></Reference><Reference><Citation>Bock AS, et al. N&#x2010;terminal acetylation modestly enhances phase separation and reduces aggregation of the low&#x2010;complexity domain of RNA&#x2010;binding protein fused in sarcoma. Protein Sci. 2021;30:1337&#x2013;1349. doi: 10.1002/pro.4029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.4029</ArticleId><ArticleId IdType="pmc">PMC8197426</ArticleId><ArticleId IdType="pubmed">33547841</ArticleId></ArticleIdList></Reference><Reference><Citation>Hershko A, Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 1998;67:425&#x2013;479. doi: 10.1146/annurev.biochem.67.1.425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.67.1.425</ArticleId><ArticleId IdType="pubmed">9759494</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandi D, Tahiliani P, Kumar A, Chandu D. The ubiquitin-proteasome system. J. Biosci. 2006;31:137&#x2013;155. doi: 10.1007/BF02705243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02705243</ArticleId><ArticleId IdType="pubmed">16595883</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Q, et al. Dysregulation of ubiquitin-proteasome system in neurodegenerative diseases. Front. Aging Neurosci. 2016;8:303. doi: 10.3389/fnagi.2016.00303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2016.00303</ArticleId><ArticleId IdType="pmc">PMC5156861</ArticleId><ArticleId IdType="pubmed">28018215</ArticleId></ArticleIdList></Reference><Reference><Citation>Mani A, Gelmann EP. The ubiquitin-proteasome pathway and its role in cancer. J. Clin. Oncol. 2005;23:4776&#x2013;4789. doi: 10.1200/JCO.2005.05.081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2005.05.081</ArticleId><ArticleId IdType="pubmed">16034054</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon S, Zhang Y, Matthias P. The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response. Genes Dev. 2007;21:3381&#x2013;3394. doi: 10.1101/gad.461107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.461107</ArticleId><ArticleId IdType="pmc">PMC2113037</ArticleId><ArticleId IdType="pubmed">18079183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu A-L, Wang J, Zheleznyak A, Brown EJ. Ubiquitin-related proteins regulate interaction of vimentin intermediate filaments with the plasma membrane. Mol. Cell. 1999;4:619&#x2013;625. doi: 10.1016/S1097-2765(00)80212-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(00)80212-9</ArticleId><ArticleId IdType="pubmed">10549293</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H-X, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao TP, et al. Ubiquitin modulates liquid-liquid phase separation of UBQLN2 via disruption of multivalent interactions. Mol. Cell. 2018;69:965&#x2013;978. e966. doi: 10.1016/j.molcel.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.02.004</ArticleId><ArticleId IdType="pmc">PMC6181577</ArticleId><ArticleId IdType="pubmed">29526694</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemasova EE, Lavrik OI. Poly (ADP-ribosyl) ation by PARP1: reaction mechanism and regulatory proteins. Nucleic Acids Res. 2019;47:3811&#x2013;3827. doi: 10.1093/nar/gkz120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz120</ArticleId><ArticleId IdType="pmc">PMC6486540</ArticleId><ArticleId IdType="pubmed">30799503</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung AK, et al. Poly (ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol. Cell. 2011;42:489&#x2013;499. doi: 10.1016/j.molcel.2011.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.04.015</ArticleId><ArticleId IdType="pmc">PMC3898460</ArticleId><ArticleId IdType="pubmed">21596313</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmeyer M, et al. Liquid demixing of intrinsically disordered proteins is seeded by poly (ADP-ribose) Nat. Commun. 2015;6:1&#x2013;12. doi: 10.1038/ncomms9088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9088</ArticleId><ArticleId IdType="pmc">PMC4560800</ArticleId><ArticleId IdType="pubmed">26286827</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y, et al. PARylation regulates stress granule dynamics, phase separation, and neurotoxicity of disease-related RNA-binding proteins. Cell Res. 2019;29:233&#x2013;247. doi: 10.1038/s41422-019-0141-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-019-0141-z</ArticleId><ArticleId IdType="pmc">PMC6460439</ArticleId><ArticleId IdType="pubmed">30728452</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L, et al. Poly (ADP-ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization. Mol. Cell. 2018;71:703&#x2013;717. e709. doi: 10.1016/j.molcel.2018.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.07.002</ArticleId><ArticleId IdType="pmc">PMC6128762</ArticleId><ArticleId IdType="pubmed">30100264</ArticleId></ArticleIdList></Reference><Reference><Citation>Meister A. Glutathione metabolism and its selective modification. J. Biol. Chem. 1988;263:17205&#x2013;17208. doi: 10.1016/S0021-9258(19)77815-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)77815-6</ArticleId><ArticleId IdType="pubmed">3053703</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson ME. Glutathione: an overview of biosynthesis and modulation. Chem. Biol. Interact. 1998;111:1&#x2013;14. doi: 10.1016/S0009-2797(97)00146-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0009-2797(97)00146-4</ArticleId><ArticleId IdType="pubmed">9679538</ArticleId></ArticleIdList></Reference><Reference><Citation>Mieyal JJ, Gallogly MM, Qanungo S, Sabens EA, Shelton MD. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid. Redox Signal. 2008;10:1941&#x2013;1988. doi: 10.1089/ars.2008.2089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2008.2089</ArticleId><ArticleId IdType="pmc">PMC2774718</ArticleId><ArticleId IdType="pubmed">18774901</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalle-Donne I, Rossi R, Giustarini D, Colombo R, Milzani A. S-glutathionylation in protein redox regulation. Free Radic. Biol. Med. 2007;43:883&#x2013;898. doi: 10.1016/j.freeradbiomed.2007.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2007.06.014</ArticleId><ArticleId IdType="pubmed">17697933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler D. Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation. Annu. Rev. Biochem. 1985;54:305&#x2013;329. doi: 10.1146/annurev.bi.54.070185.001513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.bi.54.070185.001513</ArticleId><ArticleId IdType="pubmed">2862840</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallogly MM, Mieyal JJ. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr. Opin. Pharmacol. 2007;7:381&#x2013;391. doi: 10.1016/j.coph.2007.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2007.06.003</ArticleId><ArticleId IdType="pubmed">17662654</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaus A, et al. Glutathione S-transferases interact with AMP-activated protein kinase: evidence for S-glutathionylation and activation in vitro. PLoS ONE. 2013;8:e62497. doi: 10.1371/journal.pone.0062497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0062497</ArticleId><ArticleId IdType="pmc">PMC3669356</ArticleId><ArticleId IdType="pubmed">23741294</ArticleId></ArticleIdList></Reference><Reference><Citation>Baez S, Segura-Aguilar J, Widersten M, Johansson A-S, Mannervik B. Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem. J. 1997;324:25&#x2013;28. doi: 10.1042/bj3240025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3240025</ArticleId><ArticleId IdType="pmc">PMC1218396</ArticleId><ArticleId IdType="pubmed">9164836</ArticleId></ArticleIdList></Reference><Reference><Citation>Tew KD, Ronai ZE. GST function in drug and stress response. Drug Resist. Update. 1999;2:143&#x2013;147. doi: 10.1054/drup.1999.0086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/drup.1999.0086</ArticleId><ArticleId IdType="pubmed">11504484</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghezzi P, Bonetto V, Fratelli M. Thiol&#x2013;disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxid. Redox Signal. 2005;7:964&#x2013;972. doi: 10.1089/ars.2005.7.964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2005.7.964</ArticleId><ArticleId IdType="pubmed">15998251</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon D, Board PG. A role for glutathione transferase Omega 1 (GSTO1-1) in the glutathionylation cycle. J. Biol. Chem. 2013;288:25769&#x2013;25779. doi: 10.1074/jbc.M113.487785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.487785</ArticleId><ArticleId IdType="pmc">PMC3764784</ArticleId><ArticleId IdType="pubmed">23888047</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabens Liedhegner EA, Gao X-H, Mieyal JJ. Mechanisms of altered redox regulation in neurodegenerative diseases&#x2014;focus on S-glutathionylation. Antioxid. Redox Signal. 2012;16:543&#x2013;566. doi: 10.1089/ars.2011.4119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2011.4119</ArticleId><ArticleId IdType="pmc">PMC3270051</ArticleId><ArticleId IdType="pubmed">22066468</ArticleId></ArticleIdList></Reference><Reference><Citation>Halloran M, Parakh S, Atkin J. The role of s-nitrosylation and s-glutathionylation of protein disulphide isomerase in protein misfolding and neurodegeneration. Int. J. Cell Biol. 2013;2013:797914. doi: 10.1155/2013/797914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/797914</ArticleId><ArticleId IdType="pmc">PMC3852308</ArticleId><ArticleId IdType="pubmed">24348565</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorelenkova Miller O, Mieyal JJ. Sulfhydryl-mediated redox signaling in inflammation: role in neurodegenerative diseases. Arch. Toxicol. 2015;89:1439&#x2013;1467. doi: 10.1007/s00204-015-1496-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00204-015-1496-7</ArticleId><ArticleId IdType="pubmed">25827102</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G, et al. Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells. PLoS ONE. 2011;6:e25545. doi: 10.1371/journal.pone.0025545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025545</ArticleId><ArticleId IdType="pmc">PMC3187793</ArticleId><ArticleId IdType="pubmed">21998667</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha SJ, et al. Therapeutic modulation of GSTO activity rescues FUS-associated neurotoxicity via deglutathionylation in ALS disease models. Dev. Cell. 2022;57:783&#x2013;798. e788. doi: 10.1016/j.devcel.2022.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2022.02.022</ArticleId><ArticleId IdType="pubmed">35320731</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Ye Z-w, Singh S, Townsend DM, Tew KD. An evolving understanding of the S-glutathionylation cycle in pathways of redox regulation. Free Radic. Biol. Med. 2018;120:204&#x2013;216. doi: 10.1016/j.freeradbiomed.2018.03.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.03.038</ArticleId><ArticleId IdType="pmc">PMC5940525</ArticleId><ArticleId IdType="pubmed">29578070</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter CM, Truman AW, Truttmann MC. Post-translational modifications of Hsp70 family proteins: Expanding the chaperone code. J. Biol. Chem. 2020;295:10689&#x2013;10708. doi: 10.1074/jbc.REV120.011666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.REV120.011666</ArticleId><ArticleId IdType="pmc">PMC7397107</ArticleId><ArticleId IdType="pubmed">32518165</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, et al. S-Glutathionylation of human inducible Hsp70 reveals a regulatory mechanism involving the C-terminal &#x3b1;-helical lid. J. Biol. Chem. 2020;295:8302&#x2013;8324. doi: 10.1074/jbc.RA119.012372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.012372</ArticleId><ArticleId IdType="pmc">PMC7294093</ArticleId><ArticleId IdType="pubmed">32332101</ArticleId></ArticleIdList></Reference><Reference><Citation>Gething M-J. Role and regulation of the ER chaperone BiP. Semin. Cell Dev. Biol. 1999;10:465&#x2013;472. doi: 10.1006/scdb.1999.0318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/scdb.1999.0318</ArticleId><ArticleId IdType="pubmed">10597629</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, et al. Altered redox regulation and S-glutathionylation of BiP contribute to bortezomib resistance in multiple myeloma. Free Radic. Biol. Med. 2020;160:755&#x2013;767. doi: 10.1016/j.freeradbiomed.2020.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.09.013</ArticleId><ArticleId IdType="pmc">PMC7704679</ArticleId><ArticleId IdType="pubmed">32937189</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou J, et al. STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr. Biol. 2005;15:1235&#x2013;1241. doi: 10.1016/j.cub.2005.05.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2005.05.055</ArticleId><ArticleId IdType="pmc">PMC3186072</ArticleId><ArticleId IdType="pubmed">16005298</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirko C, Novello MJ, Stathopulos PB. An S-glutathiomimetic provides structural insights into stromal interaction molecule-1 regulation. J. Mol. Biol. 2022;434:167874. doi: 10.1016/j.jmb.2022.167874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2022.167874</ArticleId><ArticleId IdType="pubmed">36332662</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>